These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9444405)

  • 1. In vivo antibacterial activity of a prodrug of NM394, a thiazetoquinoline carboxylic acid derivative.
    Ozaki M; Tomii Y; Matsuda M; Segawa J; Kitano M; Kise M; Nishino T
    Chemotherapy; 1998; 44(1):21-30. PubMed ID: 9444405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
    Shimizu M; Tabata M; Hara T; Araake M; Watabe H; Nishino T
    Jpn J Antibiot; 2002 Dec; 55(6):791-9. PubMed ID: 12621733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
    Okuyama Y; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of NM441, a new thiazeto-quinoline derivative.
    Ozaki M; Matsuda M; Tomii Y; Kimura K; Segawa J; Kitano M; Kise M; Shibata K; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2496-9. PubMed ID: 1667252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
    Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
    Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
    Nakashima M; Uematsu T; Kosuge K; Okuyama Y; Morino A; Ozaki M; Takebe Y
    J Clin Pharmacol; 1994 Sep; 34(9):930-7. PubMed ID: 7983237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
    Yoshida T; Mitsuhashi S
    Antimicrob Agents Chemother; 1993 Apr; 37(4):793-800. PubMed ID: 8388199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on pyridonecarboxylic acids. IV. Synthesis and antibacterial activity evaluation of S-(-)- and R-(+)-6-fluoro-1-methyl-4-oxo-7- (1-piperazinyl)-4H-[1,3] thiazeto[3,2-a]quinoline-3-carboxylic acids.
    Segawa J; Kazuno K; Matsuoka M; Amimoto I; Ozaki M; Matsuda M; Tomii Y; Kitano M; Kise M
    Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1238-40. PubMed ID: 7586065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acids.
    Segawa J; Kitano M; Kazuno K; Matsuoka M; Shirahase I; Ozaki M; Matsuda M; Tomii Y; Kise M
    J Med Chem; 1992 Dec; 35(25):4727-38. PubMed ID: 1335082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent.
    Tougou K; Nakamura A; Watanabe S; Okuyama Y; Morino A
    Drug Metab Dispos; 1998 Apr; 26(4):355-9. PubMed ID: 9531524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
    Araake M; Hara T; Watabe H; Nishino T
    Jpn J Antibiot; 2002 Dec; 55(6):778-90. PubMed ID: 12621732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Single-dose toxicity studies of prulifloxacin (NM441) in mice, rats and dogs and the active metabolite (NM394) in rats].
    Shimazu H; Ishikawa Y; Nishiguchi Y; Yoshida M; Iwakura K; Sumi N; Shindo Y
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():33-44. PubMed ID: 8709168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].
    Tani M; Maebashi K; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):882-5. PubMed ID: 12621742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
    Mikamo H; Kawazoe K; Izumi K; Ito K; Tamaya T
    Drugs; 1995; 49 Suppl 2():326-30. PubMed ID: 8549350
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro antibacterial activity of a new quinolone, NM394.
    Ozaki M; Matsuda M; Tomii Y; Kimura K; Kazuno K; Kitano M; Kise M; Shibata K; Otsuki M; Nishino T
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2490-5. PubMed ID: 1667251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on pyridonecarboxylic acids as antibacterial agents. XII. Synthesis and antibacterial activity of 6-chloro-1-cyclopropyl-7-(1-piperazinyl)-1, 4-dihydro-4-oxo-quinoline-3-carboxylic acid and analogues].
    Li XH; Tian ZM; Miao H; Yu LX; Guo HY
    Yao Xue Xue Bao; 1997 Nov; 32(11):844-51. PubMed ID: 11596203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes.
    Ozaki M; Komori K; Matsuda M; Yamaguchi R; Honmura T; Tomii Y; Nishimura I; Nishino T
    Antimicrob Agents Chemother; 1996 Mar; 40(3):739-42. PubMed ID: 8851603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones.
    Prats G; Roig C; Miró E; Navarro F; Mirelis B
    Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):328-34. PubMed ID: 12072950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.